Form 4 holding
Chairman, CEO and President, Director
AMGEN INC
- Security class
- Common Stock
- Shares / value
- 505,160
- Estimated value
- $177,740,546
- Report date
- 07 May 2026
- Price
- $351.85
- Ownership
- Direct
Robert A. Bradway - Chairman, CEO and President, Director at AMGEN INC
Issuer-level insider activity
- Role
- Chairman, CEO and President, Director
- Issuer ticker
- AMGN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert A. Bradway since 06 Oct 2025
Reported holdings for Robert A. Bradway in AMGEN INC
Form 4 holding
Chairman, CEO and President, Director
AMGEN INC
- Security class
- Nqso (Right to Buy)
- Shares / value
- 79,176
- Estimated value
- $23,269,198
- Report date
- 05 May 2026
- Price
- $270.44
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chairman, CEO and President, Director
AMGEN INC
- Security class
- Common Stock
- Shares / value
- 60,060
- Estimated value
- $21,132,111
- Report date
- 07 May 2026
- Price
- $351.85
- Ownership
- By GRAT
Form 4 holding
Chairman, CEO and President, Director
AMGEN INC
- Security class
- Common Stock
- Shares / value
- 60,060
- Estimated value
- $21,132,111
- Report date
- 07 May 2026
- Price
- $351.85
- Ownership
- By Spousal GRAT
Form 4 holding
Chairman, CEO and President, Director
AMGEN INC
- Security class
- Common Stock
- Shares / value
- 29,940
- Estimated value
- $10,534,389
- Report date
- 07 May 2026
- Price
- $351.85
- Ownership
- By Spouse
Transaction history for Robert A. Bradway in AMGEN INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.